Global DNA Probes-based Diagnostics Market: Overview
The global DNA probes-based diagnostics market is expected to witness robust growth in the forthcoming years. The human genome is estimated to contain about 100,000 genes and potentially, an irregularity in any of these can result in a hereditary trait or disease. DNA probes-based technology is associated with the examination of the chemical structure of DNA by undoing the presence of anomalous gene sequence on the DNA strand. It is extensively implemented in diagnostics and also in other fields such as molecular biology, microfabrication, data handling, instrumentation development, surface chemistry, and biological sample preparation. Public awareness of these techniques for prenatal diagnosis and carrier detection is rising rapidly and may result in a significant increase in the demand for such services.
This market intelligence report presents a detailed description of the dynamics impacting the growth of the global DNA probes-based diagnostics market. It analyzes various application and geographical segments of the market in terms of both revenue and volume. Primary and secondary research resources have come into play for deriving the market data and analytics. The report also profiles prominent players in the market along with their business strategies, latest developments, cost and revenue structures, and contact information. There is a separate section for recommendations, which are lucrative for both existing and new players in the market for forming their important business strategies. This report, hence, provides a 360-degree view of the global DNA probes-based diagnostics market.
Global DNA Probes-based Diagnostics Market: Drivers and Restraints
The global DNA probes-based diagnostics market is primarily driven by the increasing prominence of the technology in diagnosing infectious diseases including vaginitis. Over the past few years, the investments in pharmaceuticals and pharmacogenomics research and development have increased substantially. This has paved way for advancements in DNA array technologies, leading to the launch of new equipment facilitating execution of tests with higher speed, accuracy, and reliability and is, therefore, influencing the growth of the market positively. Moreover, the advent of novel methods for high-volume testing is augmenting the market. Growing geriatric population and rising disposable income are some of the other factors fuelling the global DNA probes-based diagnostics market.
On the other hand, there are certain limitations associated with this technology that are hampering the growth of the global market. These limitations include genetic heterogeneity, recombination between the marker and disease alleles, and incorrect pedigree data or non-paternity leading to erroneous diagnosis. However, the increasing penetration of automation in diagnosis tests is likely to create immense growth opportunities for the global DNA probes-based diagnostics market.
Global DNA Probes-based Diagnostics Market: Segmentation
On the basis of geography, the global DNA probes-based diagnostics market can be categorized into Asia Pacific, North America, Europe, and Rest of the World. North America is anticipated to command a large share throughout the forecast period, with the U.S. being the major contributor. The rapid advancements in technology in this region are enabling the complex genetic tests to shift from research laboratories to clinical and medical laboratories. Europe is also poised to experience steady growth.
The Asia Pacific market for DNA probes-based diagnostics is estimated to expand at a noteworthy CAGR during the same period owing to the improving healthcare infrastructure and increasing government funding for medical research. Moreover, factors such as the rapidly growing population, and rising healthcare expenditure are working in favor of the growth of the region.
The key application areas of the market include genetic predispositions, forensic testing, infectious diseases, molecular human leukocyte antigen (HLA), cancer testing, and others. The demand for DNA probes-based technology for diagnosing infectious disorders is likely to remain high throughout the forecast period. It is also finding increasing application in genetic predispositions.
Companies Mentioned in the Report:
The majority of the companies operating in the global DNA probes-based diagnostics market are increasingly focusing on extensive research and development in order to sustain the competition. Some of the key players are Abbott Laboratories, Affymetrix Inc, Beckman Coulter, Becton Dickinson & Company, Biogenex Laboratories Inc., bioMérieux, Genzyme Corporation, Luminex Molecular Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., QIAGEN, and MP Biomedicals, Gen-Probe Inc.
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments